Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Straumann® BLC and TLC Implants - Line extension

K-Number: K234049 · 2024-03-20

Decision Date2024-03-20
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

Straumann® BLC and TLC Implants - Line extension is a medical device manufactured by Institut Straumann AG. It received FDA 510(k) clearance on 2024-03-20 under approval number K234049. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Straumann® BLC and TLC Implants - Line extension?

Straumann® BLC and TLC Implants - Line extension is a medical device that received FDA 510(k) clearance on 2024-03-20. It is manufactured by Institut Straumann AG. The 510(k) number is K234049.

When was Straumann® BLC and TLC Implants - Line extension approved by the FDA?

Straumann® BLC and TLC Implants - Line extension received FDA 510(k) clearance on 2024-03-20, under approval number K234049.

What company makes Straumann® BLC and TLC Implants - Line extension?

Straumann® BLC and TLC Implants - Line extension is manufactured by Institut Straumann AG.

What is the FDA product code for Straumann® BLC and TLC Implants - Line extension?

The FDA product code for Straumann® BLC and TLC Implants - Line extension is DZE.

Related Clinical Trials

Other Devices by Institut Straumann AG

View all 56 devices →

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.